• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/14/2008
Trade Name:  NovoLog
Generic Name or Proper Name (*):  insulin aspart [rDNA origin] injection
Indications Studied:  Insulin analog indicated to improve glycemic control
Label Changes Summary:  * Efficacy was demonstrated in a clinical study with pediatric patients ages 4 to 18 years using an external insulin pump * New dosing regimen
Product Labeling:  Labeling  Opens a new window
Sponsor:  Novo Nordisk
Therapeutic Category:  Antidiabetic